Regulatory Disclaimer Unauthorized health products have not been approved by Health Canada, which means they have not been assessed for safety, efficacy, or quality
Lack of Physical Activity Without movement, weight loss looks flat
The perceived strength of the medication is determined by the dosage (measured in milligrams) rather than whether the medication is branded or compounded
Reviews and experiences of Wegovy vary, with many users reporting positive outcomes and some experiencing side effects
OASIS 4 Key Results 6% mean weight loss at 64 weeks among participants who remained fully adherent to treatment, compared to 2.7% for placebo a difference of nearly 14 percentage points 6% mean weight loss at 64 weeks when analyzed across all randomized participants regardless of whether they stayed on treatment, versus 2.4% for placebo One in three fully adherent participants achieved weight loss of 20% or more, compared to fewer than 3% in the placebo group Significant improvements in cardiometabolic risk factors including blood pressure, cholesterol levels, and glycemic markers were observed across the treatment group These results represent a landmark in pharmacology
only 11% of denials appealed
